Quarterly report pursuant to Section 13 or 15(d)

Marketable securities (Details Narrative)

v3.2.0.727
Marketable securities (Details Narrative) - MusclePharm [Member] - USD ($)
$ / shares in Units, $ in Thousands
10 Months Ended 12 Months Ended
Oct. 31, 2014
Dec. 31, 2014
Jan. 31, 2014
Shares receivable     1,200,000
Portion of shares in escrow 600,000    
Price per share $ 10.00    
Sale of shares $ 5,400,000    
Shares released 90,000    
Recognized loss on return of shares   $ 584,000  
Musclepharm repurchase of shares $ 250,000